294 results
8-K
EX-99.1
REGN
Regeneron Pharmaceuticals, Inc.
2 May 24
Regeneron Reports First Quarter 2024 Financial and Operating Results
7:06am
; the availability and extent of reimbursement of Regeneron’s Products from third-party payers, including private payer healthcare and insurance programs, health
8-K
EX-99.1
dfz6e0 u1jmmz
2 Feb 24
Regeneron Reports Fourth Quarter and Full Year 2023 Financial and Operating Results
7:16am
8-K
6yu7u8
31 Jan 24
Departure of Directors or Certain Officers
4:17pm
8-K
EX-99.1
k7p5bgq0bd
8 Jan 24
2 Strategy & Business Update J.P.Morgan Healthcare Conference 2024 Co - Founder, Board Co - Chair, President & Chief Executive Officer
6:30am
8-K
exuwb0x3y05blb
8 Jan 24
2 Strategy & Business Update J.P.Morgan Healthcare Conference 2024 Co - Founder, Board Co - Chair, President & Chief Executive Officer
6:30am
8-K
EX-99.1
j5pho2rsl c510
2 Nov 23
Regeneron Reports Third Quarter 2023 Financial and Operating Results
7:10am
SC TO-T/A
EX-99
wfiaxcyn lugzsslze0g
25 Sep 23
Third party tender offer statement (amended)
8:48am
SC TO-T
EX-99
g8vfrne4d4qf1chin
25 Aug 23
Third party tender offer statement
7:46am
SC TO-T
EX-99
ay8jpo70 b3x5c3r33w
25 Aug 23
Third party tender offer statement
7:46am
SC TO-C
EX-99.1
2q7s3h 0x1i44x7g
9 Aug 23
Information about tender offer
4:15pm
8-K
EX-99.1
6u5ix
3 Aug 23
Regeneron Reports Second Quarter 2023 Financial and Operating Results
6:48am
PX14A6G
4fntnb4 pe8fk
18 May 23
Letter to shareholders
4:46pm
8-K
EX-99.1
htr4574x32qujckobc
4 May 23
Regeneron Reports First Quarter 2023 Financial and Operating Results
7:11am